Orgenesis Inc. (NASDAQ:ORGS – Get Free Report) shares crossed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $0.36 and traded as low as $0.0010. Orgenesis shares last traded at $0.35, with a volume of 7,400 shares trading hands.
Orgenesis Stock Down 12.5%
The company has a market cap of $1.81 million, a P/E ratio of -0.03 and a beta of 2.86. The firm has a fifty day moving average price of $0.33 and a 200 day moving average price of $0.36.
Orgenesis Company Profile
Orgenesis Inc is a biotechnology company focused on developing and enabling cell and gene therapies. The company works on autologous cell therapies, which use a patient’s own cells, and on technologies designed to support the processing, manufacturing and delivery of these therapies.
Its activities include the development of proprietary therapeutic programs and the Orgenesis POCare platform. POCare is intended to provide decentralized, point-of-care capabilities for cell and gene therapy manufacturing, helping clinical and healthcare sites produce treatments closer to the patient under controlled processes.
Orgenesis was founded in 2011 and has pursued partnerships and operations across the United States, Europe and Israel.
Featured Stories
- Five stocks we like better than Orgenesis
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}